Best Practice & Research Clinical Gastroenterology
Volume 22, Issue 1 , Pages 45-63, February 2008

Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update

  • B.W.M. Spanier, MD

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Gastroenterology and Hepatology, Academic Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Tel.: +31 20 566 9111; Fax: +31 20 691 7033.

Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands

Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands

Over the past decades several epidemiological studies have been published reporting on incidence trends, hospital admissions, etiological factors and outcome of both acute and chronic pancreatitis. Over time, the incidence of acute pancreatitis has increased in the Western countries. Also, the number of hospital admissions for both acute and chronic pancreatitis have increased. These upward time trends possibly reflect a change in the prevalence of main etiological factors (e.g. gallstones and alcohol consumption) and cofactors such as obesity and genetic susceptibility. Acute and chronic pancreatitis are associated with significant morbidity and mortality and a substantial use of health care resources. Although the case-fatality rate of acute pancreatitis decreased over time, the overall population mortality did not change for both acute and chronic pancreatitis.

This chapter will focus on recent developments in the epidemiology, aetiology, natural course and outcome of both acute and chronic pancreatitis.

Key words: acute pancreatitis, chronic pancreatitis, epidemiology, incidence, hospital admission, aetiology, risk factors, natural course, outcome, case-fatality, mortality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosure: Axcan Pharma Incorporate, Canada sponsors B.W.M. Spanier by an unrestricted grand.

PII: S1521-6918(07)00112-6

doi:10.1016/j.bpg.2007.10.007

Best Practice & Research Clinical Gastroenterology
Volume 22, Issue 1 , Pages 45-63, February 2008